GASTROINTESTINAL TRANSIT IN CIRRHOTIC-PATIENTS - EFFECT OF HEPATIC-ENCEPHALOPATHY AND ITS TREATMENT

被引:17
|
作者
VANTHIEL, DH
FAGIUOLI, S
WRIGHT, HI
CHIEN, MC
GAVALER, JS
机构
关键词
D O I
10.1016/0270-9139(94)90054-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic hepatic encephalopathy is highly responsive to changes in diet, to antibiotic therapy and to ingestion of nondigestible disaccharides. The precise pathophysiology of chronic hepatic encephalopathy in individual cases is highly variable, although ammonia toxicity and production of neurotransmitterlike substances in the gut have been proposed to contribute to the overall syndrome of chronic hepatic encephalopathy. The support for this hypothesis is based on the empiric observation that reduction in protein intake, a catharsis or both are effective treatments for chronic hepatic encephalopathy. This study was performed to evaluate the effect of mild subclinical and low-grade (grade 0 to 1) chronic hepatic encephalopathy on gastric emptying and oral-cecal transit times. Thirty patients were studied. Ten had no evidence of chronic hepatic encephalopathy, as determined with a battery of neuropsychiatric studies (group 1); 10 had subclinical hepatic encephalopathy, as judged on the basis of abnormal neuropsychiatric test performance but normal neurological examination (group 2); and 10 had grade 1 hepatic encephalopathy. Each underwent a liquid gastric emptying study and a lactulose oral-cecal transit time study. No significant differences between groups were evident in the results of the gastric emptying studies. In contrast, the time required for a lactulose load to reach the cecum was significantly greater in the patients with hepatic encephalopathy (p < 0.01) and increased as a function of the hepatic encephalopathy grade. More interesting was that when those patients with hepatic encephalopathy were treated for 1 wk with oral neomycin (2 gm/day) and reduction in protein intake to 40 gm/day, the oral-cecal transit time declined significantly to levels seen in subjects without clinical or neuropsychiatric evidence of chronic hepatic encephalopathy. These data suggest that (a) chronic hepatic encephalopathy is associated with prolongation of oral-cecal transit that cannot be attributed to delay in gastric emptying and (b) treatment of chronic hepatic encephalopathy with antibiotics and protein restriction reduces oral-cecal transit. These data suggest but do not prove that chronic hepatic encephalopathy is a self-perpetuating disease process wherein progressive delay in oral-cecal transit allows for greater enteric production of ammonia and other putative encephalogenic materials of dietary origin.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 50 条
  • [1] GASTROINTESTINAL TRANSIT IN CIRRHOTIC-PATIENTS - THE EFFECT OF HEPATIC-ENCEPHALOPATHY
    VANTHIEL, DH
    CHIEN, MC
    GAVALER, JS
    FAGIUOLI, S
    GURAKAR, A
    CARACENI, P
    WRIGHT, HI
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A1014 - A1014
  • [2] HEPATIC-ENCEPHALOPATHY OF CIRRHOTIC-PATIENTS - IS IT CAUSED BY FALSE NEUROTRANSMITTERS
    MICHEL, H
    CUILLERET, G
    BORIES, P
    POMIERLAYRARGUES, G
    BELLET, H
    DUHAMEL, O
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1980, 4 (1BIS): : A154 - A154
  • [3] LACTITOL AND LACTULOSE FOR THE TREATMENT OF SUBCLINICAL HEPATIC-ENCEPHALOPATHY IN CIRRHOTIC-PATIENTS - A RANDOMIZED, CROSSOVER STUDY
    MORGAN, MY
    ALONSO, M
    STANGER, LC
    [J]. JOURNAL OF HEPATOLOGY, 1989, 8 (02) : 208 - 217
  • [4] EFFECTS OF DIAZEPAM ON EEG IN CIRRHOTIC-PATIENTS - DETECTION OF THE HEPATIC-ENCEPHALOPATHY RISK
    DEGOS, JD
    MEYRIGNAC, C
    KAMMERER, J
    HOUIN, G
    JARRY, GG
    [J]. NOUVELLE PRESSE MEDICALE, 1980, 9 (15): : 1097 - 1098
  • [5] PLASMA-FREE TRYPTOPHAN AS AN EARLY FINDING OF HEPATIC-ENCEPHALOPATHY IN CIRRHOTIC-PATIENTS
    SUKKAR, GS
    TESTA, R
    CELLE, G
    [J]. IRCS MEDICAL SCIENCE-BIOCHEMISTRY, 1983, 11 (11): : 999 - 999
  • [6] EFFECT OF ACUTE ADMINISTRATION OF ACAMPROSATE ON THE RISK OF HEPATIC-ENCEPHALOPATHY AND ON BLOOD-PRESSURE IN ALCOHOLIC CIRRHOTIC-PATIENTS
    DELGRANGE, T
    KHATER, J
    CAPRON, D
    DURON, B
    CAPRON, JP
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1992, 16 (8-9): : 687 - 691
  • [7] CHANGES IN PLASMA AMINO-ACIDS ACCORDING TO THE ETIOLOGY OF HEPATIC-ENCEPHALOPATHY IN CIRRHOTIC-PATIENTS
    DOFFOEL, M
    SCHLIENGER, JL
    BOCKEL, R
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1981, 5 (8-9): : 820 - 822
  • [8] MONOAMINES AND METABOLITES IN AUTOPSIED BRAIN-TISSUE FROM CIRRHOTIC-PATIENTS WITH HEPATIC-ENCEPHALOPATHY
    BERGERON, M
    READER, TA
    LAYRARGUES, GP
    BUTTERWORTH, RF
    [J]. NEUROCHEMICAL RESEARCH, 1989, 14 (09) : 853 - 859
  • [9] ACCUMULATION OF TRYPTAMINE, A POTENT NEUROACTIVE INDOLEAMINE, IN CSF AND BRAIN OF CIRRHOTIC-PATIENTS WITH HEPATIC-ENCEPHALOPATHY
    MOUSSEAU, DD
    LAYRARGUES, GP
    BUTTERWORTH, RF
    [J]. HEPATOLOGY, 1993, 18 (04) : A105 - A105
  • [10] LACTITOL VERSUS LACTULOSE IN THE TREATMENT OF ACUTE HEPATIC-ENCEPHALOPATHY IN CIRRHOTIC-PATIENTS - A DOUBLE-BLIND RANDOMIZED TRIAL
    HAWLEY, KE
    MORGAN, MY
    [J]. HEPATOLOGY, 1986, 6 (05) : 1148 - 1148